InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by O'Brien Stephanie Monaghan, Director. Officer active across 2 companies, notably Apellis Pharmaceuticals, Inc.. Aggregated, 4 disclosures have been logged. The latest transaction was filed on 1 January 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
25,666 shares
Common Stock
SEC:0001193125-26-224592·
25,666 shares
Common Stock
SEC:0001193125-26-224592:0·
04,230 shares0
Common Stock
SEC:0001127602-22-000497·
04,230 shares0
Common Stock
SEC:0001127602-22-000497:0·
4 of 4 declarations
About O'Brien Stephanie Monaghan
Stephanie Monaghan O'Brien is a Director at Apellis Pharmaceuticals, Inc. She brings expertise in management and business strategy to the board. Her role is essential in guiding strategic decisions and ensuring the sustainable growth of the company.
